# Breast Cancer Active Surveillance, Alternative Option, Aspirin Included

> **NCT03491410** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Centro Hospitalar Lisboa Ocidental** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Aspirin Low Dose
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03491410
- **Lead sponsor:** Centro Hospitalar Lisboa Ocidental
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03491410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03491410, "Breast Cancer Active Surveillance, Alternative Option, Aspirin Included". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03491410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*